SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
128.80    4.60 (3.70%)
Bid:
128.20
Ask:
129.60
Spread: 1.40 (1.092%)
Market Cap: £536.34m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

AGM Statement

2 Dec 2016 07:00

RNS Number : 7607Q
James Halstead PLC
02 December 2016
 

 

2 December 2016

JAMES HALSTEAD PLC

 

Chairman's Statement to the Annual General Meeting

 

 

James Halstead plc, the commercial flooring company, is holding its 101st AGM today at 12.00 noon at which the Chairman, Mr Geoffrey Halstead, will make the following statement: 

As is customary, I would like to give you an update on trading now that we are five months into the current financial year.

 

The fall in the value of Sterling following the referendum vote of June has contributed to increased margins on our overseas sales, increased competitiveness and positive growth although it is still early days. There are, of course, off-setting price pressures from the lower value of sterling but overall the benefit is positive.

It was noted by the CEO in the results announced on 30 September 2016 that revenues in the UK market were below last year and this has continued. Whilst we note no slippage in market share, the market is lower than last year with the best estimate of this reduction being 4 -5 %. Nevertheless, these were all known factors that our management team have factored into budgets and targets.

In recent weeks there has been significant upward pressure on the pricing of plasticiser, one of our key raw materials, due to a suspension of production following an explosion at one of BASF's European plants. BASF are not our main supplier and we have, to date, accessed appropriate volumes elsewhere in the market however their failure to supply has raised industry prices and introduced supply chain delays and shortages. This may well continue into the second half of the financial year.

 

In conclusion, trading to date has been challenging and making progress against the comparative half-year will be difficult. Our cash balances have grown and continue to be solid underpinning the 8.5p dividend to be proposed today - an increase of 8.2% on that of last year and continuing our long history of dividend growth.  I remain confident in the prospects of the Company going forward.

 

 

 

- ends -

Enquiries:

 

James Halstead:

Telephone: 0161 767 2500

Mark Halstead, Chief Executive

Gordon Oliver, Finance Director

Hudson Sandler:

Telephone: 020 7796 4133

Nick Lyon

Panmure Gordon (Nomad and Joint Brokers):

Telephone: 020 7886 2500

Ben Thorne

Andrew Potts

Arden (Joint Broker):

Telephone: 020 7614 5900

Chris Hardie

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUAOBRNWAURAA
Date   Source Headline
1st Dec 20177:00 amRNSAGM Statement
20th Oct 20173:00 pmRNSAnnual Report & Accounts
2nd Oct 20177:00 amRNSBoard Changes
2nd Oct 20177:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
14th Sep 201712:42 pmRNSNotice of Preliminary Results
14th Sep 20177:00 amRNSNotice of Preliminary Results
1st Aug 201710:43 amRNSTotal Voting Rights
1st Aug 20177:00 amRNSPre-Close Trading Statement
31st Jul 20175:53 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:40 pmRNSTotal Voting Rights
3rd Jul 20175:37 pmRNSBlock listing Interim Review
23rd Jun 20174:12 pmRNSDirector/PDMR Shareholding
12th Jun 201712:54 pmRNSDirector/PDMR Shareholding
9th Jun 20175:37 pmRNSTotal Voting Rights
12th May 20175:29 pmRNSDirector/PDMR Shareholding
12th May 20173:59 pmRNSDirector/PDMR Shareholding
5th Apr 20172:36 pmRNSDirector/PDMR Shareholding
29th Mar 20177:00 amRNSInterim Results
6th Mar 20177:00 amRNSNotice of Results
30th Jan 20177:00 amRNSPre Close Trading Statement
13th Dec 201611:13 amRNSResult of AGM
2nd Dec 20167:00 amRNSAGM Statement
1st Dec 20167:00 amRNSTotal Voting Rights
1st Nov 201612:24 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSAnnual Financial Report
3rd Oct 20167:00 amRNSPRELIMINARY ANNOUNCEMENT OF AUDITED RESULTS
21st Sep 20167:00 amRNSNotice of Preliminary Results
15th Aug 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Aug 20167:00 amRNSPre-Close Trading Statement
1st Jul 20163:41 pmRNSBlock listing Interim Review
31st Mar 20167:00 amRNSInterim Results
8th Mar 20167:00 amRNSNotice of Interim Results
1st Feb 20164:51 pmRNSTotal Voting Rights
1st Feb 20167:00 amRNSPre Close Trading Statement
3rd Dec 20155:20 pmRNSDirector/PDMR Shareholding
1st Dec 20152:45 pmRNSTotal Voting Rights
27th Nov 201512:00 pmRNSChairman's Statement to the Annual General Meeting
2nd Nov 201511:39 amRNSTotal Voting Rights
29th Oct 20154:44 pmRNSDirector/PDMR Shareholding
23rd Oct 20159:45 amRNSAnnual Financial Report & Notice of AGM
29th Sep 20157:00 amRNSFinal Results
18th Sep 20157:00 amRNSNotice of Preliminary Results
31st Jul 20157:00 amRNSTotal Voting Rights
29th Jul 20157:00 amRNSPre-Close Trading Statement
28th Jul 20156:00 pmRNSBlocklisting Interim Review
24th Jul 20155:00 pmRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSChange of Adviser
3rd Jun 20157:00 amRNSTotal Voting Rights
31st Mar 20157:00 amRNSInterim Results
20th Mar 20154:31 pmRNSNotice of Results - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.